PAPER Snape MF, Misra A, Murray TK, De Souza RJ, Williams JL, Cross AJ, Green AR

A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066.

Neuropharmacology. 1999 Jan;38(1):181-93. PubMed.

PAPER Seabrook GR, Rosahl TW

Transgenic animals relevant to Alzheimer's disease.

Neuropharmacology. 1999 Jan;38(1):1-17. PubMed.

PAPER Bergamaschini L, Canziani S, Bottasso B, Cugno M, Braidotti P, Agostoni A

Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.

Clin Exp Immunol. 1999 Mar;115(3):526-33. PubMed.

PAPER Esler WP, Stimson ER, Fishman JB, Ghilardi JR, Vinters HV, Mantyh PW, Maggio JE

Stereochemical specificity of Alzheimer's disease beta-peptide assembly.

Biopolymers. 1999 May;49(6):505-14. PubMed.

PAPER Rubin RT, Sekula LK, O'Toole S, Rhodes ME, Czambel RK

Pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration in normal women and men.

Neuropsychopharmacology. 1999 May;20(5):434-46. PubMed.

PAPER Dickson TC, King CE, McCormack GH, Vickers JC

Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease.

Exp Neurol. 1999 Mar;156(1):100-10. PubMed.

PAPER Kurkowska-Jastrzebska I, Wrońska A, Kohutnicka M, Członkowski A, Członkowska A

The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse.

Exp Neurol. 1999 Mar;156(1):50-61. PubMed.

PAPER Doody RS, Strehlow SL, Massman PJ, Feher EP, Clark C, Roy JR

Baylor profound mental status examination: a brief staging measure for profoundly demented Alzheimer disease patients.

Alzheimer Dis Assoc Disord. 1999 Jan;13(1):53-9. PubMed.

PAPER Wetherell JL, Gatz M, Johansson B, Pedersen NL

History of depression and other psychiatric illness as risk factors for Alzheimer disease in a twin sample.

Alzheimer Dis Assoc Disord. 1999 Jan;13(1):47-52. PubMed.

PAPER Tounsi H, Deweer B, Ergis AM, Van der Linden M, Pillon B, Michon A, Dubois B

Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease.

Alzheimer Dis Assoc Disord. 1999 Jan;13(1):38-46. PubMed.

PAPER Waite L, Grayson D, Jorm AF, Creasey H, Cullen J, Bennett H, Casey B, Broe GA

Informant-based staging of dementia using the clinical dementia rating.

Alzheimer Dis Assoc Disord. 1999 Jan;13(1):34-7. PubMed.

PAPER Sands LP, Katz I, Schneider L

Assessing individual patients for cognitive benefits from acetylcholinesterase inhibitors.

Alzheimer Dis Assoc Disord. 1999 Jan;13(1):26-33. PubMed.

PAPER Hampel H, Kötter HU, Padberg F, Körschenhausen DA, Möller HJ

Oligoclonal bands and blood--cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis.

Alzheimer Dis Assoc Disord. 1999 Jan;13(1):9-19. PubMed.

PAPER Zarow C, Zaias B, Lyness SA, Chui H

Cerebral amyloid angiopathy in Alzheimer disease is associated with apolipoprotein E4 and cortical neuron loss.

Alzheimer Dis Assoc Disord. 1999 Jan;13(1):1-8. PubMed.

PAPER Wang HX, Fratiglioni L, Frisoni GB, Viitanen M, Winblad B

Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study.

Am J Epidemiol. 1999 Apr 1;149(7):640-4. PubMed.